These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 9453570)

  • 21. Synaptosomal dopamine uptake in rat striatum following controlled cortical impact.
    Wilson MS; Chen X; Ma X; Ren D; Wagner AK; Reynolds IJ; Dixon CE
    J Neurosci Res; 2005 Apr; 80(1):85-91. PubMed ID: 15704194
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Modification of dopamine transporter function: effect of reactive oxygen species and dopamine.
    Berman SB; Zigmond MJ; Hastings TG
    J Neurochem; 1996 Aug; 67(2):593-600. PubMed ID: 8764584
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Modulation of the neuronal dopamine transporter activity by the metabotropic glutamate receptor mGluR5 in rat striatal synaptosomes through phosphorylation mediated processes.
    Page G; Peeters M; Najimi M; Maloteaux JM; Hermans E
    J Neurochem; 2001 Mar; 76(5):1282-90. PubMed ID: 11238713
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Iodine-123-beta-CIT and iodine-123-FPCIT SPECT measurement of dopamine transporters in healthy subjects and Parkinson's patients.
    Seibyl JP; Marek K; Sheff K; Zoghbi S; Baldwin RM; Charney DS; van Dyck CH; Innis RB
    J Nucl Med; 1998 Sep; 39(9):1500-8. PubMed ID: 9744331
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhibition by dizocilpine (MK-801) of striatal dopamine release induced by MPTP and MPP+: possible action at the dopamine transporter.
    Clarke PB; Reuben M
    Br J Pharmacol; 1995 Jan; 114(2):315-22. PubMed ID: 7881731
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Isothiocyanate derivatives of cocaine: irreversible inhibition of ligand binding at the dopamine transporter.
    Boja JW; Rahman MA; Philip A; Lewin AH; Carroll FI; Kuhar MJ
    Mol Pharmacol; 1991 Mar; 39(3):339-45. PubMed ID: 1826041
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of 1,2,3,4,-tetrahydroisoquinoline administration under conditions of CYP2D inhibition on dopamine metabolism, level of tyrosine hydroxylase protein and the binding of [3H]GBR 12,935 to dopamine transporter in the rat nigrostriatal, dopaminergic system.
    Lorenc-Koci E; Antkiewicz-Michaluk L; Wardas J; Zapała M; Wierońska J
    Brain Res; 2004 May; 1009(1-2):67-81. PubMed ID: 15120584
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Glial cell line-derived neurotrophic factor (GDNF) gene delivery protects dopaminergic terminals from degeneration.
    Connor B; Kozlowski DA; Unnerstall JR; Elsworth JD; Tillerson JL; Schallert T; Bohn MC
    Exp Neurol; 2001 May; 169(1):83-95. PubMed ID: 11312561
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Paraquat induces long-lasting dopamine overflow through the excitotoxic pathway in the striatum of freely moving rats.
    Shimizu K; Matsubara K; Ohtaki K; Fujimaru S; Saito O; Shiono H
    Brain Res; 2003 Jun; 976(2):243-52. PubMed ID: 12763259
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Studies of the biogenic amine transporters. VIII: identification of a novel partial inhibitor of dopamine uptake and dopamine transporter binding.
    Rothman RB; Dersch CM; Carroll FI; Ananthan S
    Synapse; 2002 Mar; 43(4):268-74. PubMed ID: 11835522
    [TBL] [Abstract][Full Text] [Related]  

  • 31. High affinity hydroxypiperidine analogues of 4-(2-benzhydryloxyethyl)-1-(4-fluorobenzyl)piperidine for the dopamine transporter: stereospecific interactions in vitro and in vivo.
    Ghorai SK; Cook C; Davis M; Venkataraman SK; George C; Beardsley PM; Reith ME; Dutta AK
    J Med Chem; 2003 Mar; 46(7):1220-8. PubMed ID: 12646032
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mercuric chloride and p-chloromercuriphenylsulfonate exert a biphasic effect on the binding of the stimulant [3H]methylphenidate to the dopamine transporter.
    Schweri MM
    Synapse; 1994 Mar; 16(3):188-94. PubMed ID: 8197581
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effects of methamphetamine on serotonin transporter activity: role of dopamine and hyperthermia.
    Haughey HM; Fleckenstein AE; Metzger RR; Hanson GR
    J Neurochem; 2000 Oct; 75(4):1608-17. PubMed ID: 10987842
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Binding of bromine-substituted analogs of methylphenidate to monoamine transporters.
    Pan D; Gatley SJ; Dewey SL; Chen R; Alexoff DA; Ding YS; Fowler JS
    Eur J Pharmacol; 1994 Oct; 264(2):177-82. PubMed ID: 7851480
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In vitro and in vivo characterization of newly developed iodinated 1-[2-[bis(4-fluorophenyl)methoxy]ethyl]piperazine derivatives in rats: limited value as dopamine transporter SPECT ligands.
    Rijks LJ; Booij J; Doornbos T; Boer GJ; Ronken E; de Bruin K; Vermeulen RJ; Janssen AG; Van Royen EA
    Synapse; 1996 Jul; 23(3):201-7. PubMed ID: 8807748
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synthesis and characterization of technetium-99m-labeled tropanes as dopamine transporter-imaging agents.
    Meegalla SK; Plössl K; Kung MP; Chumpradit S; Stevenson DA; Kushner SA; McElgin WT; Mozley PD; Kung HF
    J Med Chem; 1997 Jan; 40(1):9-17. PubMed ID: 9016323
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Modeling of the pH dependence of the binding of WIN 35,428 to the dopamine transporter in rat striatal membranes: is the bioactive form positively charged or neutral?
    Xu C; Reith ME
    J Pharmacol Exp Ther; 1996 Sep; 278(3):1340-8. PubMed ID: 8819521
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Chronic levodopa is not toxic for remaining dopamine neurons, but instead promotes their recovery, in rats with moderate nigrostriatal lesions.
    Murer MG; Dziewczapolski G; Menalled LB; García MC; Agid Y; Gershanik O; Raisman-Vozari R
    Ann Neurol; 1998 May; 43(5):561-75. PubMed ID: 9585350
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Anatomic and biochemical correlates of the dopamine transporter ligand 11C-PE2I in normal and parkinsonian primates: comparison with 6-[18F]fluoro-L-dopa.
    Poyot T; Condé F; Grégoire MC; Frouin V; Coulon C; Fuseau C; Hinnen F; Dollé F; Hantraye P; Bottlaender M
    J Cereb Blood Flow Metab; 2001 Jul; 21(7):782-92. PubMed ID: 11435790
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Increased synaptosomal dopamine content and brain concentration of paraquat produced by selective dithiocarbamates.
    Barlow BK; Thiruchelvam MJ; Bennice L; Cory-Slechta DA; Ballatori N; Richfield EK
    J Neurochem; 2003 May; 85(4):1075-86. PubMed ID: 12716439
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.